| Name | Title | Contact Details |
|---|---|---|
Heather Walsh |
Senior Director Human Resources | Profile |
Brent Jones |
Executive Vice President and Chief Financial Officer | Profile |
Stephanie Hoelscher |
Sr. Talent Acquisition Partner | Profile |
Jeff Tissier |
Director of Regional Sales | Profile |
Rebekah Harvey |
Sr. Director, Sales Enablement | Profile |
LIGNO TECH USA is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Seer is a life sciences and health data company focused on capturing and translating deep molecular insights from the proteome to enable early detection of cancer and neurological diseases, drive earlier treatment, and improve patient outcomes.
Kyn Therapeutics is building a new generation of immuno-oncology therapies targeting powerful immunosuppressive metabolic networks. We envision a future where immunotherapies are the foundation of every cancer patient`s treatment, delivering rapid and durable responses. The Kyn team is composed of drug hunters, translational researchers and entrepreneurs drawn from many of the largest innovators in biotechnology supported by world-class advisors, and is backed by a seasoned board of directors anchored by OrbiMed Healthcare Fund Management and Atlas Venture. Kyn Therapeutics is headquartered in the biotech hub of Cambridge, Massachusetts.
Oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies.
BIOAGE has a diverse team of computational biologists and medical scientists with expertise in aging and translational research. We share the vision that a synergy of machine learning approaches, high throughput human omics data, and new experimental approaches will make it possible to discover therapies that address unmet medical needs in an aging population.